Our results confirm that imrecoxib can inhibit EMT of paraquat-induced A549 cells and alleviate paraquat-induced pulmonary fibrosis through the NF-κB/snail signal pathway. This evidence concerns the gene SNAI1 and pulmonary fibrosis.